ID

29684

Descripción

A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection; ODM derived from: https://clinicaltrials.gov/show/NCT00423891

Link

https://clinicaltrials.gov/show/NCT00423891

Palabras clave

  1. 11/4/18 11/4/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

11 de abril de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Hepatitis B, Chronic NCT00423891

Eligibility Hepatitis B, Chronic NCT00423891

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
2-18 years of age
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
group a: lamivudine naive (<1 week of lamivudine) and not within 24 weeks of screening; group b: lamivudine experienced (> 12 weeks of lamivudine); group c: nucleoside/nucleotide experienced (> 12 weeks of nucleoside/tide therapy) added as a country-specific protocol amendment (not all sites had group c).
Descripción

Lamivudine naive | Lamivudine | Nucleosides | Nucleotides

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0209738
UMLS CUI [1,2]
C0919936
UMLS CUI [2]
C0209738
UMLS CUI [3]
C0028621
UMLS CUI [4]
C0028630
hbv deoxyribonucleic acid (dna) ≥ 100000 copies/ml; ≥ 10000 copies for nucleoside/nucleotide experienced (group c)
Descripción

Hepatitis B DNA Measurement | Nucleosides | Nucleotides

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3641250
UMLS CUI [2]
C0028621
UMLS CUI [3]
C0028630
detectable hepatitis b surface antigen (hbsag) for 24 weeks prior to screening
Descripción

Hepatitis B Surface Antigens Detectable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019168
UMLS CUI [1,2]
C3830527
hepatitis b e antigen (hbeag) positive
Descripción

Hepatitis B e antigen positive

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392390
compensated liver and renal function
Descripción

Liver function Compensated | Renal function Compensated

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0232741
UMLS CUI [1,2]
C0205432
UMLS CUI [2,1]
C0232804
UMLS CUI [2,2]
C0205432
elevated alanine aminotransferase (alt) at screening and during the 24 weeks prior to screening (for groups a and b)
Descripción

Alanine aminotransferase increased

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0151905
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
coinfection with human immunodeficiency virus (hiv), hepatitis c virus (hcv), hepatitis d virus (hdv)
Descripción

HIV coinfection | HCV coinfection | HDV Coinfection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4062778
UMLS CUI [2]
C1698259
UMLS CUI [3,1]
C0011220
UMLS CUI [3,2]
C0275524
children who were breastfed while their mother received lamivudine, or children whose mothers received lamivudine during pregnancy
Descripción

Children | Mother Lamivudine Breast Feeding | Mother Lamivudine Pregnancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0008059
UMLS CUI [2,1]
C0026591
UMLS CUI [2,2]
C0209738
UMLS CUI [2,3]
C0006147
UMLS CUI [3,1]
C0026591
UMLS CUI [3,2]
C0209738
UMLS CUI [3,3]
C0032961

Similar models

Eligibility Hepatitis B, Chronic NCT00423891

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
2-18 years of age
boolean
C0001779 (UMLS CUI [1])
Lamivudine naive | Lamivudine | Nucleosides | Nucleotides
Item
group a: lamivudine naive (<1 week of lamivudine) and not within 24 weeks of screening; group b: lamivudine experienced (> 12 weeks of lamivudine); group c: nucleoside/nucleotide experienced (> 12 weeks of nucleoside/tide therapy) added as a country-specific protocol amendment (not all sites had group c).
boolean
C0209738 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
C0209738 (UMLS CUI [2])
C0028621 (UMLS CUI [3])
C0028630 (UMLS CUI [4])
Hepatitis B DNA Measurement | Nucleosides | Nucleotides
Item
hbv deoxyribonucleic acid (dna) ≥ 100000 copies/ml; ≥ 10000 copies for nucleoside/nucleotide experienced (group c)
boolean
C3641250 (UMLS CUI [1])
C0028621 (UMLS CUI [2])
C0028630 (UMLS CUI [3])
Hepatitis B Surface Antigens Detectable
Item
detectable hepatitis b surface antigen (hbsag) for 24 weeks prior to screening
boolean
C0019168 (UMLS CUI [1,1])
C3830527 (UMLS CUI [1,2])
Hepatitis B e antigen positive
Item
hepatitis b e antigen (hbeag) positive
boolean
C0392390 (UMLS CUI [1])
Liver function Compensated | Renal function Compensated
Item
compensated liver and renal function
boolean
C0232741 (UMLS CUI [1,1])
C0205432 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2,1])
C0205432 (UMLS CUI [2,2])
Alanine aminotransferase increased
Item
elevated alanine aminotransferase (alt) at screening and during the 24 weeks prior to screening (for groups a and b)
boolean
C0151905 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
HIV coinfection | HCV coinfection | HDV Coinfection
Item
coinfection with human immunodeficiency virus (hiv), hepatitis c virus (hcv), hepatitis d virus (hdv)
boolean
C4062778 (UMLS CUI [1])
C1698259 (UMLS CUI [2])
C0011220 (UMLS CUI [3,1])
C0275524 (UMLS CUI [3,2])
Children | Mother Lamivudine Breast Feeding | Mother Lamivudine Pregnancy
Item
children who were breastfed while their mother received lamivudine, or children whose mothers received lamivudine during pregnancy
boolean
C0008059 (UMLS CUI [1])
C0026591 (UMLS CUI [2,1])
C0209738 (UMLS CUI [2,2])
C0006147 (UMLS CUI [2,3])
C0026591 (UMLS CUI [3,1])
C0209738 (UMLS CUI [3,2])
C0032961 (UMLS CUI [3,3])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial